Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kit C B Roes

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Drug Discovery Today|January 19, 2013
Should non-inferiority drug trials be banned altogether?Grace Wangge, Olaf H Klungel, Kit C B Roes, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Predicting enrollment performance of investigational centers in phase III multi-center clinical trialsRutger M van den Bor, Diederick E Grobbee, Bas J Oosterman, et al.
American Journal of Epidemiology|January 21, 2012
Dealing with missing outcome data in randomized trials and observational studiesRolf H H Groenwold, A Rogier T Donders, Kit C B Roes, et al.
Nature Communications|June 24, 2021
In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trialsAli Sarrami-Foroushani, Toni Lassila, Michael MacRaild, et al.
Systematic Reviews|April 25, 2015
Meta-analyses triggered by previous (false-)significant findings: problems and solutionsEwoud Schuit, Kit C B Roes, Ben W J Mol, et al.
Drug Discovery Today|September 26, 2017
European regulatory use and impact of subgroup evaluation in marketing authorisation applicationsJulien Tanniou, Steven Teerenstra, Sagal Hassan, et al.
Journal of Neurology|September 23, 2020
A word of hope for ataxia trials in COVID-19 time and beyondRoderick P P W M Maas, Jordache Ramjith, Thomas Klockgether, et al.
Trials|April 3, 2014
Improving clinical trial efficiency by biomarker-guided patient selectionRuud Boessen, Hiddo J Lambers Heerspink, Dick De Zeeuw, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2020
Breast Cancer and Major Deviations of Genetic and Gender-related Structures and FunctionHerjan J T Coelingh Bennink, Jan F M Egberts, Jan A Mol, et al.
Pharmacogenomics|April 3, 2012
Potential of adaptive clinical trial designs in pharmacogenetic researchFrederieke H van der Baan, Mirjam J Knol, Olaf H Klungel, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Drug Discovery Today|January 19, 2013
Should non-inferiority drug trials be banned altogether?Grace Wangge, Olaf H Klungel, Kit C B Roes, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Predicting enrollment performance of investigational centers in phase III multi-center clinical trialsRutger M van den Bor, Diederick E Grobbee, Bas J Oosterman, et al.
American Journal of Epidemiology|January 21, 2012
Dealing with missing outcome data in randomized trials and observational studiesRolf H H Groenwold, A Rogier T Donders, Kit C B Roes, et al.
Nature Communications|June 24, 2021
In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trialsAli Sarrami-Foroushani, Toni Lassila, Michael MacRaild, et al.
Systematic Reviews|April 25, 2015
Meta-analyses triggered by previous (false-)significant findings: problems and solutionsEwoud Schuit, Kit C B Roes, Ben W J Mol, et al.
Drug Discovery Today|September 26, 2017
European regulatory use and impact of subgroup evaluation in marketing authorisation applicationsJulien Tanniou, Steven Teerenstra, Sagal Hassan, et al.
Journal of Neurology|September 23, 2020
A word of hope for ataxia trials in COVID-19 time and beyondRoderick P P W M Maas, Jordache Ramjith, Thomas Klockgether, et al.
Trials|April 3, 2014
Improving clinical trial efficiency by biomarker-guided patient selectionRuud Boessen, Hiddo J Lambers Heerspink, Dick De Zeeuw, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2020
Breast Cancer and Major Deviations of Genetic and Gender-related Structures and FunctionHerjan J T Coelingh Bennink, Jan F M Egberts, Jan A Mol, et al.
Pharmacogenomics|April 3, 2012
Potential of adaptive clinical trial designs in pharmacogenetic researchFrederieke H van der Baan, Mirjam J Knol, Olaf H Klungel, et al.
Pageof 11